Hyderabad, Oct 2: Dr Reddy’s Laboratories Limited on Tuesday announced that its wholly owned subsidiary Promius Pharma, LLC, has sold its rights of Cloderm Cream, 0.1 per cent and its authorized generic to EPI Health, LLC, an affiliate of EPI Group, LLC.
Under the terms of the agreement, Promius Pharma is eligible to receive an upfront payment followed by future royalties as the consideration for Cloderm Cream and its authorized generic in the United States, effective immediately, a company statement here said.
“We look forward to EPI continuing to support Cloderm, a brand that providers have prescribed for several decades and find as an important treatment option for their patients. ” Anil Namboodiripad, Senior Vice President, Proprietary Products, and President, Promius Pharma said. (UNI)